Brief: Repare Therapeutics Provides Business Update And Reports Q4 And FY 2022 Financial Results
Feb 28 (Reuters) - Repare Therapeutics Inc RPTX.O :
* REPARE THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
* REPARE THERAPEUTICS-CASH, CASH EQUIVALENTS MARKETABLE
SECURITIES
AS OF DEC 31, 2022 $343.9 MILLION, WHICH CO BELIEVES TO BE
ENOUGH TO FUND OPERATIONS INTO 2026
* QTRLY LOSS PER SHARE $0.75
* Q4 EARNINGS PER SHARE VIEW $-0.72 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw8bntkya
Further company coverage: RPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln